no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients
|
Winkle, Peter |
|
|
37 |
4 |
p. 743-755 |
article |
2 |
2-Arachidonoylglycerol Attenuates Myocardial Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway
|
Chen, Zhengjie |
|
|
37 |
4 |
p. 647-654 |
article |
3 |
2-Arachidonoylglycerol in Cardiovascular Disease: Angel or Demon?
|
Cui, Jinzhen |
|
|
37 |
4 |
p. 617 |
article |
4 |
Association between Body Mass Index and Clinical Outcomes in Patients with Non-valvular Atrial Fibrillation Receiving Direct Oral Anticoagulants: A New Piece of Evidence on the Obesity Paradox from China
|
Wu, Shuyi |
|
|
37 |
4 |
p. 715-727 |
article |
5 |
Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
|
Puccini, Marianna |
|
|
37 |
4 |
p. 833-837 |
article |
6 |
Cardiac Effects of Phosphodiesterase-5 Inhibitors: Efficacy and Safety
|
Roy, Sumon |
|
|
37 |
4 |
p. 793-806 |
article |
7 |
Closing the Digitalis Divide: Back to the Basics of Randomized Controlled Trials
|
Triska, J. |
|
|
37 |
4 |
p. 807-813 |
article |
8 |
Correction to: Effect of Insulin Resistance on Recurrence After Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation
|
Wang, Zhe |
|
|
37 |
4 |
p. 613 |
article |
9 |
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
|
Michaeli, Daniel Tobias |
|
|
37 |
4 |
p. 683-694 |
article |
10 |
Dual Antiplatelet Therapy with 3rd Generation P2Y12 Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose–Response
|
Scudiero, Fernando |
|
|
37 |
4 |
p. 695-703 |
article |
11 |
Effect of Insulin Resistance on Recurrence after Radiofrequency Catheter Ablation in Patients with Atrial Fibrillation
|
Wang, Zhe |
|
|
37 |
4 |
p. 705-713 |
article |
12 |
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes
|
Kawada, Tomoyuki |
|
|
37 |
4 |
p. 619-620 |
article |
13 |
Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update
|
Vaz-Salvador, Pedro |
|
|
37 |
4 |
p. 815-832 |
article |
14 |
Interleukin-35 Mitigates ox-LDL-Induced Proatherogenic Effects via Modulating miRNAs Associated with Coronary Artery Disease (CAD)
|
Bhansali, Shipra |
|
|
37 |
4 |
p. 667-682 |
article |
15 |
MicroRNA-145 in Cardiovascular Disease: an Insufficiently Explored and Controversial Research Area
|
Xu, Yingchun |
|
|
37 |
4 |
p. 615-616 |
article |
16 |
MircroRNA-145 Attenuates Cardiac Fibrosis Via Regulating Mitogen-Activated Protein Kinase Kinase Kinase 3
|
Liu, Yun |
|
|
37 |
4 |
p. 655-665 |
article |
17 |
Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Versus Warfarin in Patients with Atrial Fibrillation Using P-gp and/or CYP450-Interacting Drugs: a Systematic Review and Meta-analysis
|
Grymonprez, Maxim |
|
|
37 |
4 |
p. 781-791 |
article |
18 |
Recombinant Apyrase (AZD3366) Against Myocardial Reperfusion Injury
|
Birnbaum, Yochai |
|
|
37 |
4 |
p. 625-646 |
article |
19 |
Results from the “Me & My Heart” (eMocial) Study: a Randomized Evaluation of a New Smartphone-Based Support Tool to Increase Therapy Adherence of Patients with Acute Coronary Syndrome
|
Krackhardt, Florian |
|
|
37 |
4 |
p. 729-741 |
article |
20 |
Surgical or Percutaneous Coronary Revascularization for Heart Failure: a Focus on Symptoms and Stenosis
|
Sulzgruber, Patrick |
|
|
37 |
4 |
p. 623-624 |
article |
21 |
The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases
|
Strauss, Martin H. |
|
|
37 |
4 |
p. 757-770 |
article |
22 |
The Effect of Hydroxychloroquine on Cardiovascular Disease in Patients with Rheumatoid Arthritis
|
Mo, De-Gang |
|
|
37 |
4 |
p. 621-622 |
article |
23 |
Treatment and Prophylaxis of Post-pericardiotomy Syndrome in Cardiac Surgery Patients: a Systematic Review
|
Giacinto, Omar |
|
|
37 |
4 |
p. 771-779 |
article |